That immune activation acting through IDO induction in the periphery or the brain can also induce a central serotonin deficiency is exemplified by the incidence of depression in hepatitis C virus (HCV) patients treated with the IDO inducer interferon-α (IFN-α) (see [12] and references cited therein). This evidence concerns the gene IDO1 and depressive disorder.